Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients()

Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the...

Descripción completa

Detalles Bibliográficos
Autores principales: Acea-Nebril, Benigno, García-Novoa, Alejandra, Bouzón Alejandro, Alberto, Díaz Carballada, Carlota, Conde Iglesias, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598034/
https://www.ncbi.nlm.nih.gov/pubmed/37857128
http://dx.doi.org/10.1016/j.breast.2023.103592
Descripción
Sumario:Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the axillary staging method during surgery remains controversial. There are at least three validated methods: SLNB, targeted axillary dissection (TAD) and marking axillary nodes with radioactive iodine seeds (MARI) procedure. Our house believe that the biopsied and clipped lymph node could predict response to systemic treatment.

Ejemplares similares